About Vineti

Industry-leading experts providing safety, security, seamlessness, and scalability

A company purpose-built for personalized therapies

From the beginning, Vineti’s founders have understood the challenges that biotech and pharmaceutical innovators face in developing personalized therapies. The emerging ecosystem of cell therapies, gene therapies, and personalized cancer vaccines requires new enabling technologies to align and manage production processes and the patient journey. Our patent pending Personalized Therapy Management (PTM) platform provides the next-generation technology that advanced therapies need. In 2019, the World Economic Forum selected Vineti for its prestigious Technology Pioneer honor, as a company with the potential to “improve society for years to come.”

Meet our team

Our mission

The Vineti team is united in our passion and commitment to opening up access to advanced therapies. With the number of new personalized therapies in development continuing to grow, Vineti is paving the way for efficiency, access, and global reach. As a leader in personalized therapy digital technology, Vineti is working to create a world where individualized therapies can reach all who need them.

Personalized therapy innovators are ambitious in their aims to serve patients and transform healthcare. The Vineti team works every day to enable those ambitions. Together, we will help your advanced therapy reach more patients, faster.

The name Vineti derives from an ancient word that invokes the idea of progress by eliminating obstacles to accomplish a goal.

Vineti's founding and what's next

Co-founded by GE Ventures and the Mayo Clinic, the Vineti team came together to solve the need for a compliant, validated, scalable solution to support personalized therapy workflows. Our aim is to solve the complexities of personalized therapies by providing advanced technology strategies and solutions for all stakeholders. With Series C funding from top-tier investors, Vineti continues to help to break down barriers to the advancement of personalized medicines with growth in Europe and Asia-Pacific.

Originally called Vitruvian Networks, the company became Vineti in 2017.